arrow
J

José R. Conejo-García

duke school of medicine
H指数:72
被引数:2.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Olaparib plus tremelimumab in women with recurrent ovarian cancer and a germline BRCA1 or BRCA2 mutation: a phase I/II study

奥拉帕利联合曲美木单抗在携带胚系BRCA1或BRCA2突变且复发卵巢癌女性中的疗效:一项I/II期研究

2026-10-080
OA
Ovarian cancer tumor immune profiles associated with intrauterine device and oral contraceptive use

与宫内节育器和口服避孕药使用相关的卵巢癌肿瘤免疫图谱

2026-06-270
OA
Rethinking ovarian cancer III: the past decade and future directions

重新思考卵巢癌III:过去十年及未来方向

2026-04-130
PRE
SIRT2-mediated deacetylation of LCK governs the magnitude of T cell receptor signaling

LCK的SIRT2-mediated脱乙酰化控制T细胞受体信号的大小

2026-01-290
OAAI
Anti-PD-L2 immunotherapy is efficacious against melanoma in aged hosts through IL-17 and IFNγ signalling

抗PD-L2免疫疗法通过IL-17和IFNγ信号通路对老年宿主中的黑色素瘤具有疗效。

2025-11-190
OAAI
The promise of TIL therapy for glioblastoma

胶质母细胞瘤中肿瘤浸润淋巴细胞疗法的潜力

2025-11-130
PRE
Vgd1 and Vgd3 T cells infiltrate non-small/small cell lung cancer, high-grade serous ovarian carcinoma and can be expanded from human umbilical cord blood for allogeneic CAR-T cell therapies
2025-11-010
PRE
SPATIAL MULTI-OMIC PROFILING REVEALS DETERMINANTS OF TIL EXPANDABILITY IN HIGH-GRADE GLIOMAS

空间多组学分析揭示了高分级胶质瘤中肿瘤浸润淋巴细胞扩增能力的决定因素

2025-10-010
PRE
Myeloid cell networks govern re-establishment of original immune landscapes in recurrent ovarian cancer

髓系细胞网络调控复发性卵巢癌中原有免疫景观的重新建立

2025-07-310
OAAI
Profiling antigen-binding affinity of B cell repertoires in tumors by deep learning predicts immune-checkpoint inhibitor treatment outcomes

通过深度学习分析肿瘤中B细胞库的抗原结合亲和力,可预测免疫检查点抑制剂治疗结局

2025-06-270
PRE
Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapy

在非响应TIL细胞疗法的患者中,转移性非小细胞肺癌时间序列分析显示T细胞和新生抗原保留受损

2025-05-080
PRE
A working group report from the 2024 National Cancer Institute / Gynecologic Cancer Steering Committee endometrial cancer clinical trials planning meeting: refining the approach to endometrial cancer in the immunotherapy era

2024年国家癌症研究所/妇科癌症指导委员会子宫内膜癌临床试验规划会议工作组报告:在免疫治疗时代完善子宫内膜癌的治疗方法

2025-04-110
PRE